Aducanumab and the Medicalization (Still) of Alzheimer's Disease: A Challenge to Measure and Act On What Matters
J Gerontol Nurs
.
2021 Sep;47(9):2-4.
doi: 10.3928/00989134-20210806-01.
Epub 2021 Sep 1.
Author
Donna M Fick
PMID:
34432574
DOI:
10.3928/00989134-20210806-01
No abstract available
Publication types
Editorial
MeSH terms
Alzheimer Disease* / drug therapy
Antibodies, Monoclonal, Humanized
Humans
Medicalization
Substances
Antibodies, Monoclonal, Humanized
aducanumab